Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Sao Paulo Med J ; 140(2): 182-187, 2022.
Article in English | MEDLINE | ID: covidwho-1706149

ABSTRACT

BACKGROUND: Prevention of recurrence of stroke depends on recognition of the underlying mechanism of ischemia. OBJECTIVE: To screen patients who were hospitalized with diagnosis of acute ischemic stroke in terms of atrial fibrillation (AF) with repeated Holter electrocardiography recordings. DESIGN AND SETTING: Prospective study conducted at Konya Education and Research Hospital, Turkey. METHODS: Patients with a diagnosis of acute ischemic stroke, without atrial fibrillation on electrocardiography (ECG), were evaluated. Their age, gender, histories of previous ischemic attack, occurrences of paroxysmal atrial fibrillation (PAF) and other risks were assessed during the first week after acute ischemic stroke and one month thereafter. ECG recordings were obtained from 130 patients through 24-hour ambulatory Holter. Patients without PAF attack during the first Holter were re-evaluated. RESULTS: PAF was detected through the first Holter in 33 (25.4%) out of 130 acute ischemic stroke patients. A second Holter was planned for 97 patients: 53 (54.6%) of them could not attend due to COVID-19 pandemic; while 44 (45.3%) patients had the second Holter and, among these, 4 (9.1%) had PAF. The only parameter associated with PAF was older age. Four (10.8%) of the 37 patients with PAF had also symptomatic carotid stenosis. CONCLUSIONS: Detecting the presence of PAF by screening patients with no AF in the ECG through Holter ECG examinations is valuable in terms of changing the course of the treatment. It should be kept in mind that the possibility of accompanying PAF cannot be ruled out in the presence of other factors that pose a risk of stroke.


Subject(s)
Atrial Fibrillation , COVID-19 , Ischemic Stroke , Stroke , Atrial Fibrillation/complications , Atrial Fibrillation/epidemiology , Electrocardiography, Ambulatory/adverse effects , Humans , Pandemics , Prospective Studies , Risk Factors , Stroke/complications
2.
Sao Paulo Med J ; 139(2): 190-195, 2021.
Article in English | MEDLINE | ID: covidwho-1090499

ABSTRACT

BACKGROUND: Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spectrum are emerging as information is shared. CASE REPORT: We present the case of a pregnant woman who was diagnosed with venous sinus thrombosis after she developed headache and hemiparesis. Polymerase chain reaction (PCR) positivity lasted for two weeks after COVID-19 had been diagnosed. CONCLUSIONS: In patients with suspected COVID-19, especially in the presence of causes of hypercoagu- lability and presence of atypical features, venous sinus thrombosis needs to be kept in mind in making the differential diagnosis.


Subject(s)
COVID-19/complications , Headache/etiology , SARS-CoV-2 , Venous Thrombosis/diagnosis , COVID-19/diagnosis , COVID-19 Testing , China , Female , Humans , Paresis/etiology , Polymerase Chain Reaction , Pregnancy , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Sinus Thrombosis, Intracranial/diagnostic imaging , Thrombophilia
SELECTION OF CITATIONS
SEARCH DETAIL